Today in America Reviews The Latest In Headache Treatments with Migraine Treatment Centers

Today in America reviews effective new migraine treatment by a Texas based group of medical professionals dedicated to the treatment of migraines. in “Medical Minutes” series. (PRWeb February 05, 2012) Read the full story at http://www.prweb.com/releases/today-in-america-mcta/02/prweb9165528.htm

PuraMed BioScience, Inc. Announces LipiGesic®M, Their Unique Migraine Treatment, is Now Available for Purchase at CVS ...

SCHOFIELD, Wis., Jan. 25, 2012 /PRNewswire/ -- PuraMed BioScience, Inc. (OTCBB: PMBS.OB - News) announced today that LipiGesic M, their clinically proven effective and safe, all natural product for the treatment ...

UPDATE 1-Impax Labs licenses Astrazeneca's migraine drug in US

(Follows alerts) Feb 1 (Reuters) - Impax Laboratories said ithas licensed AstraZeneca's migraine treatment, Zomig, inthe United States and will pay quarterly payments totaling $130million during 2012 to ...

NuPathe Announces Allowance of Additional U.S. Patent Application for Its Migraine Patch

CONSHOHOCKEN, PA-- - NuPathe Inc. , an emerging biopharmaceutical company focused on the development and commercialization of branded therapeutics for diseases of the central nervous system, today announced ...

UBM Medica's ConsultantLive Offers Migraine Diagnostic Help for Clinicians

NORWALK, Conn. , Jan. 18, 2012 /PRNewswire/ -- UBM Medica's announced today that ConsultantLive now features special coverage focused on helping clinicians diagnose and control migraine headaches .With ...

Impax acquires US rights to migraine drug Zomig

Impax Laboratories Inc. has acquired the U.S. rights to AstraZeneca PLC's migraine headache drug Zomig. The deal sent Impax's shares soaring Wednesday.